x
0 Activities
0 Activities
No Saved Activities
Please wait
Home
Education
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
Search Education
Register
Contact Us
Login
Login
Remember Me
Log in
Create an account
Forgot your password?
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Adaptive Learning
Animation
EXPLORE™
Downloads
Interactive Case
Microlearning
Podcast
Video
Webinar
Credits
Specialty Area
Disease Area
Start
«
1
2
3
4
5
6
7
8
»
End
Page 6 of 8
Results 376 - 450 of 535
15
30
60
75
150
Eugene’s U(I)P-Hill Battle
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult
Is Mary’s PAH Making You Dizzy?
Jeff’s COPD is No Smoke!
Clearing the Air on Chuck’s Asthma
Shedding Light on Jane’s ILD Diagnosis
When Should You Consider Palliative Care in the Patient Journey?
What is Your Treatment Recommendation for Sandra’s CTEPH?
Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?
New Tools to Improve the Diagnosis of IPF vs Other ILDs
New Research on Therapies for Patients with Pulmonary Fibrosis
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
2019 Summer Pulmonary Updates: The Experts Weigh In
Urgency for Early Diagnosis and Treatment of SMA
Reporting HRCT Findings for ILD from a Multidisciplinary Team
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
SMA: Data, Insights and Practice
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
Biosimilars: Applying the Science to Hematology/Oncology Practice
Management of Mycobacterium Abscessus Lung Disease
Difficult to Treat Mycobacterium Avium Complex Lung Disease
Management of Mycobacterium Avium Complex Lung Disease
The Latest from a Recent Pulmonary Conference in San Antonio
Updates in Inoperable CTEPH
The Importance of Early Integration of Palliative Care
Management of IPF Patients in 2018
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
Overview of the Latest Clinical Trials in IPF
Evolution of Antifibrotic Therapy in IPF
Take Home Messages from the 2018 CHEST Annual Meeting
What We’re Learning from the IPF-PRO Registry
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
Emerging Treatments for NTM Lung Disease
Nontuberculous Mycobacteria Case 2: Alan
NTM and Treatment Strategies for Patients with Cavitary Disease
New Findings in the Treatment of MAC Lung Disease
Why You Should Pay Attention to NTM Treatment Guidelines
Which of Your Patients Are at Risk for NTM?
Practice Improvement through ILD Centers and Community Partnerships
Improving the Care for IPF Patients Using a Team-Based Approach
An Early Integrated Palliative Care Delivery Model for Patients with IPF
Treatment Challenges with MAC Lung Disease
Nontuberculous Mycobacteria: Summary
Treatment Challenges with MABC Lung Disease
Nontuberculous Mycobacteria Case 1: Maria
NTM – To Treat or Not to Treat
Goals of NTM Treatment
Guideline-recommended Treatments for NTM
Diagnosis of NTM
Factors Associated with Respiratory Involvement in NTM
Most Common Species in NTM Lung Disease
Nontuberculous Mycobacteria: Introduction and Epidemiology
Atopic Dermatitis: Putting it Together (Dermatology)
Atopic Dermatitis: Putting it Together (Primary Care)
Atopic Dermatitis: Recent and Emerging Therapies
An Introduction to Atopic Dermatitis
PAH Today: Mastering Current, Tailored Treatment
Achieving Better Control of Severe Asthma
A Personalized Approach to Managing Uncontrolled Asthma
Proper Use of an Inhaler
Top Questions about Biosimilars in Dermatology
Top Questions about Biosimilars in Gastroenterology
Top Questions about Biosimilars in Rheumatology
Top Questions about Biosimilars in Hematology/Oncology
Biosimilars and Patients with Inflammatory Bowel Disease
Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
Environmental Influences on the Development of Pulmonary Fibrosis
Gene Abnormalities and ILD
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
Updates on Registry Enrollment and Growth of the Care Center Network
New Approaches to the Diagnosis of IPF
Exploring New Therapeutic Avenues for Managing PF
New Research on Mechanisms in the Development of PF
Start
«
1
2
3
4
5
6
7
8
»
End
Page 6 of 8
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept